| Proposed Ticker: PURE | 1308 North Magnolia Avenue, Suite H | |
| Exchange: NASDAQ-Small Cap Market | El Cajon, California 92020 | |
| Industry: Manufacturing | (619) 441-8233 |
| All share information is proposed | ||||
| Type of Shares: | Common Shares | Filing Date: | 1/18/96 | |
| U.S. Shares Filed: | 1,250,000 | Filing Price: | $4.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $5,000,000 | |
| Primary Shares: | 1,250,000 | Expenses: | $180,000 | |
| Secondary Shares: | 0 | Shs Out After: | 3,828,851 | |
| Manager | Tier | Phone |
| Meyers Pollock Robbins, Inc. | Lead Manager | (212) 323-3000 |
| Monitor Investment Group, Inc. | Lead Manager |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 7/31/95 | 7/31/95 | ||||
| Revenue: | $0.46 | Assets: | $0.43 | ||
| Net Income: | $0.00 | Liabilities: | $0.19 | ||
| EPS: | $0.00 | Equity: | $0.23 | ||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is a California corporation formed on August 24, 1992 to engage principally in the business of manufacturing and marketing the Fillmaster, a unique product developed by the company. The Fillmaster is a water purification system with a calibrated volumetric measuring and dispensing apparatus that provides measured amounts of "Purified Water" for use in the reconstitution of prescription medications, generally oral antibiotics. At the present time, the company is only marketing this single product. The current method used by Pharmacists to measure and mix water in prescription medications is typically to pour or siphon water from bottles and then manually measure and mix the water with powdered compounds. This method is time consuming and blindly relies upon the purity of the bottled water, any equipment used, as well as into the prescription itself. The company believes that the Fillmaster is unique because it not only reduces the potential of contamination of the water source and cross-contamination of the final product but also provides the Pharmacist with cost savings over bottled water and a significantly faster and simpler means of drawing and measuring water and hence dispensing prescriptions. |
| Use of Proceeds |
| Proceeds from the proposed offering will be used to further develop its medical and pharmaceutical service product, manufacturing and marketing. |
©1996 IPO Data Systems, Inc. - All rights reserved.